Related Experiment Video
Updated: May 17, 2026

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening
Published on: October 26, 2017
Identification of circulating microRNAs as biomarkers in cancers: what have we got?
Yu Sun1, Kuo Zhang, Gaowei Fan
1Beijing Hospital ofthe Ministry of Health, Beijing, People's Republic of China.
Abstract:
During the past few years there has been great interest in the development of circulating microRNAs (miRNAs) as stable blood-based biomarkers for cancer detection. Deregulation of miRNAs in blood samples has shown considerable clinical utilities in cancers. Due to poorly characterized preanalytical and analytical variables and the lack of a standardized measurement protocol, the application of these miRNA fingerprints is hindered by conflicting results. In this review,we outline our current understanding of preanalytically and analytically confounding factors. We believe that great consideration should be taken in the development of circulating miRNA as tumor biomarkers.
More Related Videos
Related Concept Videos
MicroRNAs
MicroRNAs
lncRNA - Long Non-coding RNAs

